Ken Griffin Epizyme, Inc. Transaction History

Citadel Advisors LLC

$483 Billion
Q2 2024

Shares

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2022 Aug 15, 2022	SELL	$0.42 - $1.48 $1.48 Million - $5.2 Million	-3,512,608 Reduced 83.55%	691,458 $1.02 Million
Q1 2022 May 16, 2022	BUY	$1.06 - $2.68 $3.63 Million - $9.19 Million	3,427,731 Added 441.53%	4,204,066 $4.83 Million
Q4 2021 Feb 14, 2022	BUY	$2.5 - $5.19 $1.84 Million - $3.82 Million	736,685 Added 1857.97%	776,335 $1.94 Million
Q3 2021 Nov 15, 2021	SELL	$4.82 - $8.46 $131,099 - $230,103	-27,199 Reduced 40.69%	39,650 $203,000
Q2 2021 Aug 16, 2021	SELL	$6.81 - $9.71 $37,094 - $52,890	-5,447 Reduced 7.53%	66,849 $555,000
Q1 2021 May 17, 2021	SELL	$7.45 - $12.32 $5.45 Million - $9.02 Million	-731,872 Reduced 91.01%	72,296 $630,000
Q4 2020 Feb 16, 2021	BUY	$10.34 - $13.77 $6.21 Million - $8.27 Million	600,305 Added 294.46%	804,168 $8.73 Million
Q3 2020 Nov 16, 2020	BUY	$11.73 - $16.25 $897,649 - $1.24 Million	76,526 Added 60.1%	203,863 $2.43 Million
Q2 2020 Aug 14, 2020	BUY	$13.68 - $20.46 $1.18 Million - $1.77 Million	86,422 Added 211.22%	127,337 $2.05 Million
Q1 2020 May 15, 2020	BUY	$14.83 - $26.72 $244,991 - $441,414	16,520 Added 67.72%	40,915 $634,000
Q4 2019 Feb 14, 2020	SELL	$9.77 - $24.6 $5.39 Million - $13.6 Million	-551,496 Reduced 95.76%	24,395 $600,000
Q3 2019 Nov 14, 2019	BUY	$10.17 - $13.86 $3.18 Million - $4.33 Million	312,399 Added 118.56%	575,891 $5.94 Million
Q4 2018 Feb 14, 2019	BUY	$5.22 - $10.44 $900,528 - $1.8 Million	172,515 Added 189.62%	263,492 $1.62 Million
Q3 2018 Nov 13, 2018	SELL	$9.5 - $13.75 $6.83 Million - $9.89 Million	-719,142 Reduced 88.77%	90,977 $0
Q2 2018 Aug 10, 2018	BUY	$12.85 - $18.45 $2.94 Million - $4.21 Million	228,405 Added 39.26%	810,119 $0
Q1 2018 May 11, 2018	BUY	$12.5 - $19.75 $370,312 - $585,093	29,625 Added 5.37%	581,714 $10.3 Million
Q4 2017 Feb 09, 2018	BUY	$11.55 - $20.1 $1.32 Million - $2.3 Million	114,240 Added 26.09%	552,089 $6.93 Million
Q3 2017 Nov 09, 2017	BUY	$12.7 - $19.25 $5.56 Million - $8.43 Million	437,849	437,849 $8.34 Million

About Epizyme, Inc.

Ticker EPZM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 168,364,992
Market Cap $247M

More about EPZM

Track Ken Griffin's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.